ACROBiosystems

ACROBiosystems Group (Stock Code: 301080) is a multinational biotechnology company established in 2010. It serves as an industry platform-based cornerstone enterprise, providing key biological reagent products and solutions to the global biopharmaceutical and health industries. ACROBiosystems Group was listed on the Growth Enterprise Market in 2021. The group operates globally across Asia, North America, and Europe, with offices, R&D centers, and production bases in 12 cities, including in China, the United States, and Switzerland. To date, it has served over 6,000 customers and established long-term, stable partnerships with the world’s top 20 pharmaceutical companies. Under its corporate umbrella, the group owns brands such as ACROBiosystems, bioSeedin (VCBeat), Condense Capital, and ACRODiagnostics. Sub-brands of ACROBiosystems include MembraneMasterpiece, Star Staining, ViruStop, Aneuro, ComboX, ActiveMax, and GENPower. Its main products and services include proteins, antibodies, kits, and analytical testing services, which are applied in drug screening and optimization, preclinical experiments and clinical trials, drug manufacturing processes and process control (CMC), diagnostic reagent development and optimization, and other R&D and production phases for diseases such as cancer, autoimmune disorders, cardiovascular diseases, infectious diseases, and neurological conditions. With the mission of accelerating the research, development, and market launch of biopharmaceuticals and serving better clinical applications, ACROBiosystems Group strives to create value for its clients and the entire global industry. By continuously updating its technology, products, and services, the company actively empowers its partners to accelerate the R&D, market launch, and clinical application of various biopharmaceuticals, including targeted therapies and immunotherapies, ultimately contributing to the advancement of human health.